27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
On Tuesday, Oct. 30, Pfizer, Inc. (NYSE:PFE) will release its latest earnings report. Decipher the announcement with Benzinga's help.
Earnings and Revenue
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Pfizer EPS is expected to be around 75 cents, according to sell-side analysts. Sales will likely be near $13.55 billion.
Pfizer EPS in the same period a year ago totaled 67 cents. Sales were $13.17 billion. If the company were to match the consensus estimate when it reports Tuesday, earnings would be up 11.94 percent. Revenue would be have grown 2.9 percent from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:
Quarter | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 |
EPS Estimate | 0.74 | 0.74 | 0.56 | 0.64 |
EPS Actual | 0.81 | 0.77 | 0.62 | 0.67 |
Stock Performance
Over the last 52-week period, shares are up 17.81 percent. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release. Analysts have adjusted their estimates higher for EPS and revenues over the past 90 days. The popular rating by analysts on Pfizer stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
Conference Call
Pfizer's Q3 conference call is scheduled to begin at 10:00 a.m. ET and can be accessed here: https://www.webcaster4.com/Webcast/Page/748/27452
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.